Original Research and the Latest News
Recent Posts
When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency
Predicting when a competing product will be approved is essential in any commercial forecast and for any business insights team...
Letting the Data Tell the Story
In our previous post we described the technique for assigning categories to data, based on input from content experts within a...
Using NLP Data to Classify Patient Segments in Clinical Trial Data
One of the most common and powerful approaches in NLP provides the content experts an opportunity to label each data segment for...
The Future of Innovation in Diabetes & Heart Disease
When it comes to improving the lives of patients with chronic illnesses like type-2 diabetes and heart disease, the...
The Clinical Trial Powershift
Pharmaceutical companies are being pushed aside when it comes to who is driving clinical outcomes. Despite the growing number of...
Tango Therapeutics: Early Stage Oncology Pipeline Comes Into Focus in April
The Annual Meeting of the American Association for Cancer Research (AACR) is taking place April 5-10 in San Diego. AACR...
Novo Nordisk Diabetes Pipeline Analysis
Novo Nordisk remains a top player in the Diabetes market with blockbuster insulins NovoLog® and Levemir® which brought in a...
ELI LILLY in the Diabetes Market
For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast-acting analog Humalog® and human...
China Reshaping the Clinical Trial Pipeline
Finally, the data is in here at OZMOSI, and we can start tracking and reporting on the clinical development expected to come out...
Merck Diabetes Pipeline Analysis
Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in...
Keeping up with the Pharmaceutical Industry in Asia
Keeping up with the pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some...
Building a Case Study Portfolio Framework
When a pharmaceutical company in China realized it needed outside help to identify and close the gaps in its R&D portfolio,...
Case Study Market Scan – Understanding the Competition and Defining Opportunity
A small startup medical device company needed a broader understanding of its potential competitors and a more complete picture...
Forecasting – Applying Pharmaceutical Valuation Approach in the Foster Care Setting
The Children’s Hospital of Philadelphia–Policy Lab approached Ozmosi for help in supporting its application for federal funding...
Pharma Forecasting Case Study – Valuing the Impact of Development Delays
A multinational pharmaceutical firm asked Ozmosi to provide forecasts to assess the market impact of delays in delivering new...
Case Study Portfolio – Prioritization aligning teams on value and risk and guiding investment
The Asia-Pacific R&D unit of a large, multinational pharmaceutical company needed a pipeline prioritization approach to...
Case Study Market Scan – Surveying Pharmaceutical Markets in Asia Pacific
A regional marketing team for a multinational pharmaceutical company needed a complete market overview of a neuroscience therapy...
PHARMA FORECASTING CASE STUDY – Estimating the Prevalence of Orphan Diseases
When in-house experts’ forecasts for the market potential of a treatment for an orphan disease conflicted, the management team...
Recent Tweets
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762